Compare GALT & INSW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GALT | INSW |
|---|---|---|
| Founded | 2000 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 261.1M | 2.6B |
| IPO Year | N/A | N/A |
| Metric | GALT | INSW |
|---|---|---|
| Price | $4.17 | $48.61 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 1 |
| Target Price | $8.50 | ★ $48.00 |
| AVG Volume (30 Days) | ★ 813.8K | 473.3K |
| Earning Date | 11-14-2025 | 11-06-2025 |
| Dividend Yield | N/A | ★ 6.04% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 4.39 |
| Revenue | N/A | ★ $770,036,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $4.22 |
| P/E Ratio | ★ N/A | $11.06 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.07 | $27.20 |
| 52 Week High | $7.13 | $55.18 |
| Indicator | GALT | INSW |
|---|---|---|
| Relative Strength Index (RSI) | 36.28 | 43.81 |
| Support Level | $3.90 | $47.62 |
| Resistance Level | $4.19 | $49.45 |
| Average True Range (ATR) | 0.54 | 1.04 |
| MACD | -0.19 | -0.03 |
| Stochastic Oscillator | 17.22 | 43.07 |
Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.
International Seaways Inc owns and operates a fleet of oceangoing vessels engaged in the transportation of crude oil and petroleum products. The company's vessel operations are organized into two segments: Crude Tankers and Product Carriers. The fleet consists of ULCC, VLCC, Suezmax, Aframax, and Panamax crude tankers, as well as LR1, LR2, and MR product carriers.